{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:34:42Z","timestamp":1788798882886,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ymthe.2023.02.003","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T02:22:22Z","timestamp":1675822942000},"page":"1002-1016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Jong Bin","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Won","family":"Seol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Sang","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Young","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taek-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youkyeong Gloria","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Pyo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Suk","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Myoung","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gou Young","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabbine","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1270-0413","authenticated-orcid":false,"given":"Yong-Mahn","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.02.003_bib1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.02.003_bib2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/2271173b0","article-title":"The enzyme defect in Fabry's disease","volume":"227","author":"Kint","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.02.003_bib3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.112.195685","article-title":"Vascular aspects of fabry disease in relation to clinical manifestations and elevations in plasma globotriaosylsphingosine","volume":"60","author":"Rombach","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ymthe.2023.02.003_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.2007.08002.x","article-title":"Fabry disease and the skin: data from FOS, the Fabry outcome survey","volume":"157","author":"Orteu","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymthe.2023.02.003_bib5","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","article-title":"Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy","volume":"24","author":"Schiffmann","year":"2009","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.ymthe.2023.02.003_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2023.02.003_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2009.10.004","article-title":"Vasculopathy in patients with Fabry disease: current controversies and research directions","volume":"99","author":"Rombach","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2023.02.003_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human \u03b1-galactosidase a replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.02.003_bib9","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in fabry disease a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.ymthe.2023.02.003_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"Long-term safety and efficacy of enzyme replacement therapyfor fabry disease","volume":"75","author":"Wilcox","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2023.02.003_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","article-title":"Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment","volume":"119","author":"Weidemann","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2023.02.003_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1681\/ASN.2006080816","article-title":"Sustained, long-term renal stabilization after 54\u00a0months of agalsidase beta therapy in patients with Fabry disease","volume":"18","author":"Germain","year":"2007","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2023.02.003_bib58","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s40265-021-01486-1","article-title":"Fabry Disease: The Current Treatment Landscape","volume":"81","author":"Lenders","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2023.02.003_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057631","article-title":"Migalastat HCl reduces globotriaosylsphingosine (lyso-Gb3) in Fabry transgenic mice and in the plasma of Fabry patients","volume":"8","author":"Young-Gqamana","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.02.003_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1750-1172-7-91","article-title":"Safety and pharmacodynamic effects of a pharmacological chaperone on \u03b1-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies","volume":"7","author":"Germain","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2023.02.003_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102633","article-title":"Enhanced thrombospondin-1 causes dysfunction of vascular endothelial cells derived from Fabry disease-induced pluripotent stem cells","volume":"52","author":"Do","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2023.02.003_bib16","doi-asserted-by":"crossref","first-page":"227ra34","DOI":"10.1126\/scitranslmed.3006927","article-title":"TGF-\u03b2 signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling","volume":"6","author":"Cooley","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2023.02.003_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fcell.2020.00260","article-title":"TGF-\u03b2-Induced endothelial to mesenchymal transition in disease and tissue engineering","volume":"8","author":"Ma","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2023.02.003_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1750-1172-8-116","article-title":"Fibrosis: a key feature of Fabry disease with potential therapeutic implications","volume":"8","author":"Weidemann","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2023.02.003_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102157","article-title":"TGF-\u03b2-Induced endothelial-mesenchymal transition in fibrotic diseases","volume":"18","author":"Pardali","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2023.02.003_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3727\/096368916X694265","article-title":"Imbalanced production of reactive oxygen species and mitochondrial antioxidant SOD2 in fabry disease-specific human induced pluripotent stem cell-differentiated vascular endothelial cells","volume":"26","author":"Tseng","year":"2017","journal-title":"Cell Transpl."},{"key":"10.1016\/j.ymthe.2023.02.003_bib21","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1073\/pnas.96.11.6423","article-title":"Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice","volume":"96","author":"Ohshima","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.02.003_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BJ20130825","article-title":"A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis","volume":"456","author":"Taguchi","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2023.02.003_bib23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1096\/fj.201800771R","article-title":"\u03b1-Galactosidase A-deficient rats accumulate glycosphingolipids and develop cardiorenal phenotypes of Fabry disease","volume":"33","author":"Miller","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2023.02.003_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijcard.2008.03.007","article-title":"Onset and progression of the Anderson-Fabry disease related cardiomyopathy","volume":"130","author":"Kampmann","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ymthe.2023.02.003_bib25","article-title":"Mechanisms of mitochondrial dysfunction in lysosomal storage disorders: a review","volume":"9","author":"Stepien","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.ymthe.2023.02.003_bib26","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"\u03b1-Galactosidase A deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.02.003_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00005-015-0382-6","article-title":"Novel insights into the roles of rho kinase in cancer","volume":"64","author":"Wei","year":"2016","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.ymthe.2023.02.003_bib28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/01.RES.0000096650.91688.28","article-title":"Long-Term inhibition of rho-kinase suppresses angiotensin II\u2013induced cardiovascular hypertrophy in rats in\u00a0vivo","volume":"93","author":"Higashi","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2023.02.003_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204618","article-title":"Oxidative stress and the altered reaction to it in Fabry disease: a possible target for cardiovascular-renal remodeling?","volume":"13","author":"Ravarotto","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.02.003_bib30","doi-asserted-by":"crossref","first-page":"R1014","DOI":"10.1152\/ajpregu.00124.2004","article-title":"Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology","volume":"287","author":"Li","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ymthe.2023.02.003_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fphys.2018.00105","article-title":"Oxidative stress and renal fibrosis: recent insights for the development of novel therapeutic strategies","volume":"9","author":"Lv","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymthe.2023.02.003_bib32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cmet.2013.12.014","article-title":"Endothelial PGC-1\u03b1 mediates vascular dysfunction in diabetes","volume":"19","author":"Sawada","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2023.02.003_bib33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1227\/01.NEU.0000147975.24556.BC","article-title":"Treatment of cerebral vasospasm with intra-arterial fasudil hydrochloride","volume":"56","author":"Tanaka","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ymthe.2023.02.003_bib34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13287-015-0147-5","article-title":"Impaired osteogenesis in Menkes disease-derived induced pluripotent stem cells","volume":"6","author":"Kim","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ymthe.2023.02.003_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2022.103001","article-title":"Generation of a CRISPR\/Cas9-corrected-hiPSC line (DDLABi001-A) from Fabry disease (FD)-derived iPSCs having \u03b1-galactosidase (GLA) gene mutation (c.803_806del)","volume":"66","author":"Choi","year":"2023","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.ymthe.2023.02.003_bib36","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1182\/blood-2010-04-280719","article-title":"Efficient differentiation of human pluripotent stem cells into functional CD34+ progenitor cells by combined modulation of the MEK\/ERK and BMP4 signaling pathways","volume":"116","author":"Park","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.02.003_bib37","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/nprot.2014.102","article-title":"Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells","volume":"9","author":"Orlova","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2023.02.003_bib38","first-page":"2012","article-title":"Contribution: angiogenesis analyzer","volume":"5","author":"Carpentier","year":"2012","journal-title":"ImageJ News"},{"key":"10.1016\/j.ymthe.2023.02.003_bib39","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.stemcr.2021.06.007","article-title":"Dysregulated ECM remodeling proteins lead to aberrant osteogenesis of Costello syndrome iPSCs","volume":"16","author":"Choi","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymthe.2023.02.003_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ymeth.2016.11.016","article-title":"DiAna, an ImageJ tool for object-based 3D co-localization and distance analysis","volume":"115","author":"Gilles","year":"2017","journal-title":"Methods (San Diego, Calif.)"},{"key":"10.1016\/j.ymthe.2023.02.003_bib41","first-page":"2114","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics (Oxford, England)"},{"key":"10.1016\/j.ymthe.2023.02.003_bib42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2023.02.003_bib43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2023.02.003_bib44","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/nprot.2016.095","article-title":"Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown","volume":"11","author":"Pertea","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2023.02.003_bib45","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2023.02.003_bib46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2023.02.003_bib47","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2023.02.003_bib48","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1523\/JNEUROSCI.17-11-04275.1997","article-title":"Norepinephrine facilitates the development of the murine sweat response but is not essential","volume":"17","author":"Tafari","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2023.02.003_bib49","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1152\/japplphysiol.01508.2011","article-title":"Modified iodine-paper technique for the standardized determination of sweat gland activation","volume":"112","author":"Gagnon","year":"2012","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.ymthe.2023.02.003_bib50","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.amjsurg.2016.01.020","article-title":"Frey's syndrome after superficial parotidectomy: role of the sternocleidomastoid muscle flap: a prospective nonrandomized controlled trial","volume":"212","author":"Grosheva","year":"2016","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.ymthe.2023.02.003_bib51","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/sj.mt.6300066","article-title":"Correction of the biochemical and functional deficits in fabry mice following AAV8-mediated hepatic expression of \u03b1-galactosidase A","volume":"15","author":"Ziegler","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.02.003_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015033","article-title":"Substrate reduction augments the efficacy of enzyme therapy in a mouse model of Fabry disease","volume":"5","author":"Marshall","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.02.003_bib53","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.echo.2017.08.006","article-title":"Application of speckle-tracking echocardiography in an experimental model of isolated subendocardial damage","volume":"30","author":"Beyhoff","year":"2017","journal-title":"J.\u00a0Am. Soc. Echocardiography"},{"key":"10.1016\/j.ymthe.2023.02.003_bib54","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1038\/s41598-020-60594-2","article-title":"Speckle-tracking echocardiography combined with imaging mass spectrometry assesses region-dependent alterations","volume":"10","author":"Pappritz","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2023.02.003_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1476-7120-12-40","article-title":"Diastolic wall strain: a simple marker of abnormal cardiac mechanics","volume":"12","author":"Selvaraj","year":"2014","journal-title":"Cardiovasc. Ultrasound"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:08:07Z","timestamp":1761502087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001623000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1525001623000667"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.02.003","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}